{
  "pmid": "27872459",
  "uid": "27872459",
  "title": "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel",
      "initials": "H",
      "name": "Hertzel Gerstein",
      "affiliations": []
    },
    {
      "last_name": "Jaeschke",
      "fore_name": "Roman",
      "initials": "R",
      "name": "Roman Jaeschke",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Polskie Archiwum Medycyny Wewnetrznej",
    "iso_abbreviation": "Pol Arch Med Wewn",
    "volume": "126",
    "issue": "10",
    "pub_year": "2016",
    "pub_month": "Oct",
    "pub_day": "28"
  },
  "start_page": "803",
  "end_page": "805",
  "pages": "803-805",
  "language": "eng",
  "publication_types": [
    "Interview"
  ],
  "keywords": [
    "Benzhydryl Compounds",
    "Diabetes Mellitus, Type 2",
    "Glucosides",
    "Humans",
    "Hypoglycemic Agents",
    "Practice Guidelines as Topic",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "27872459",
    "doi": "10.20452/pamw.3612"
  },
  "doi": "10.20452/pamw.3612",
  "dates": {
    "completed": "2017-04-25",
    "revised": "2017-08-17"
  },
  "chemicals": [
    "Benzhydryl Compounds",
    "Glucosides",
    "Hypoglycemic Agents",
    "empagliflozin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:30:17.511420",
    "pmid": "27872459"
  }
}